Prasugrel Versus Placebo in Adult Sickle Cell Disease

Clinical trial NCT01167023 · COMPLETED

Trial details

NCT number: NCT01167023
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Anemia

Start date: 2010-07-01
Primary completion: 2011-06-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.